GENERAL

GENERAL

2 – Should aspirin be stopped pre-operatively in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10840

3 – What is the optimal management of patients who are on antiplatelet medications prior to an elective orthopaedic procedure? https://icmphilly.com/?page_id=10880

4 – What is the optimal management of patients who are on antiplatelet medications prior to an emergency orthopaedic procedure? https://icmphilly.com/?page_id=10890

5 – When should chronic anticoagulation be stopped in patients undergoing elective orthopaedic procedures? https://icmphilly.com/?page_id=10305

6 – Should bridging by an injectable anticoagulation be considered in patients who are on chronic anticoagulation prior to undergoing elective orthopaedic procedures? https://icmphilly.com/?page_id=10467

7 – Should the VTE prophylaxis be altered in patients undergoing orthopaedic procedures who develop wound-related problems? https://icmphilly.com/?page_id=10501

8 – Is there an association between pulmonary embolus and secondary pulmonary hypertension after major orthopaedic surgery? https://icmphilly.com/?page_id=10555

9 – Are there adverse consequences of not treating acute lower extremity DVT in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10530

10 – Does the development of a hematoma as a result of the administration of VTE prophylaxis increase the risk of subsequent arthrofibrosis? https://icmphilly.com/?page_id=10917

11 – Does the administration of VTE prophylaxis to patients undergoing orthopedic procedures increase the rate of post-operative non-VTE complications? https://icmphilly.com/?page_id=10731

12 – Does the administration of VTE prophylaxis increase the risk for epidural hematoma in patients undergoing orthopaedic procedures?  If so, are there differences between the various agents? https://icmphilly.com/?page_id=10559

13 – Does the administration of VTE prophylaxis increase the risk for intracranial bleeding in patients undergoing orthopaedic procedures? If so, are there differences between the various prophylactic agents? https://icmphilly.com/?page_id=10693

14 – Should venous thromboembolism (VTE) screening be performed in asymptomatic patients undergoing orthopaedic surgery? https://icmphilly.com/?page_id=10497

16 – Are there any serological biomarkers for the diagnosis of DVT/PE? https://icmphilly.com/?page_id=10567

17 – What is the optimal imaging modality for detection of upper and lower extremity DVT for patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10437

20 – Do venous filling defects seen on cross-sectional imaging of the lung always represent a PE? https://icmphilly.com/?page_id=10425

21 – Is there a role for lower extremity venograms for the diagnosis of lower extremity DVT? https://icmphilly.com/?page_id=10667

25 – Does post-operative rehabilitation protocol such as early ambulation influence the incidence of VTE after orthopaedic procedures? https://icmphilly.com/?page_id=10617

26 – Is there a role for the use of compression stockinette in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10375

29 – Are there specific contraindications for the administration of each VTE prophylactic agent? https://icmphilly.com/?page_id=10748

30 – Are there differences between various VTE prophylaxis in terms of patient compliance/adherence? https://icmphilly.com/?page_id=10760

31 – Can NSAID be used as prophylactic agents against VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10508

32 – Can NSAID be co-administered with aspirin, when used as a VTE prophylaxis, in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10713

33 – What VTE prophylaxis should be administered to a patient who is allergic to aspirin? https://icmphilly.com/?page_id=10190

34 – Is there a difference between low dose and regular dose aspirin for the prevention of VTE following orthopaedic procedures? https://icmphilly.com/?page_id=10194

36 – Is there a role for sequential combination VTE prophylaxis in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10513

38 – Should the dose of LMWH for the prevention of VTE be weight-adjusted? https://icmphilly.com/?page_id=10571

39 – What is the optimal timing for the start of LMWH as a VTE prophylaxis in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10350

40 – Is there a role for bridging with another therapeutic anticoagulant after orthopaedic surgery when warfarin is used for VTE prophylaxis? https://icmphilly.com/?page_id=10764

41 – Are there differences between various factor Xa inhibitors for management of VTE with regard to efficacy and safety profile? https://icmphilly.com/?page_id=10718

42 – Are there any blood tests that can be used to monitor the activity/efficacy of factor Xa inhibitors used as VTE prophylaxis? https://icmphilly.com/?page_id=10176

44 – Does warfarin cause hypercoagulable state during initial administration? https://icmphilly.com/?page_id=10198

46 – Do all emboli detected on cross-sectional imaging of the lung lead to the same degree of oxygenation compromise (hypoxia)? https://icmphilly.com/?page_id=10575

47 – Are there genetic predisposing factors for VTE? https://icmphilly.com/?page_id=10595

50 – What are the indications for seeking a thrombosis specialist or a hematology consult for VTE prevention, in patients undergoing elective orthopaedic procedures? https://icmphilly.com/?page_id=10517

51 – Is there a correlation between age and the risk of VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10331

52 – Is there a role for stratification of patients undergoing orthopaedic procedures for risk of bleeding?  If so, should VTE prophylaxis be altered based on bleeding risk profile? https://icmphilly.com/?page_id=10622

53 – Is there a validated risk stratification scoring system that can be used for determining VTE risk of a patient undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10325

57 – Is the risk of VTE following orthopaedic procedures related to ethnicity or race? If yes, should VTE prophylaxis be altered or changed based on race and/or ethnicity? https://icmphilly.com/?page_id=10539

58 – Is there a definite association between BMI and VTE? https://icmphilly.com/?page_id=10671

59 – Does the type of anesthesia administered influence the risk of VTE in orthopedic surgery? https://icmphilly.com/?page_id=10210

61 – Does tourniquet applied to the lower extremity influence the incidence of post-operative VTE? https://icmphilly.com/?page_id=10526

62 – Does tourniquet applied to upper extremity influence the incidence of post-operative VTE? https://icmphilly.com/?page_id=10521

63 – Does the duration of surgery influence the incidence of postoperative VTE? https://icmphilly.com/?page_id=10445

64 – Does the volume of intraoperative blood loss influence the incidence of post-operative VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10234

65 – Does administration of allogeneic blood transfusion influence the incidence of post-operative VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10311

66 – Does the use of PMMA cement during orthopaedic procedures influence the risk of subsequent VTE? https://icmphilly.com/?page_id=10580

67 – Does the intra-operative positioning of a patient undergoing orthopaedic surgery influence the risk of subsequent VTE? https://icmphilly.com/?page_id=10371

69 – Does the type (DVT vs. PE) or timing (remote vs. recent) of prior VTE influence the risk of subsequent VTE following orthopaedic procedures? https://icmphilly.com/?page_id=10493

71 – Is administration of any VTE prophylaxis effective in reducing the risk of fatal PE? https://icmphilly.com/?page_id=10535

72 – How long after a diagnosed DVT and/or PE can a patient undergo elective orthopaedic procedure? https://icmphilly.com/?page_id=10626

73 – When do VTE episodes occur after orthopaedic procedures? https://icmphilly.com/?page_id=10367

75 – Does the location of PE in the lung, as detected by imaging, influence the type of anticoagulation treatment that may be administered? https://icmphilly.com/?page_id=10654

76 – How should patients with post-operative distal DVT be managed? https://icmphilly.com/?page_id=10658

77 – How should patients with post-operative proximal (popliteal or supra-popliteal) DVT be managed? https://icmphilly.com/?page_id=10689

80 – Does the presence of varicosities and/or superficial lower extremity thrombosis increase the risk of VTE in patients undergoing orthopedic procedures? https://icmphilly.com/?page_id=10450

84 – Do patients with an underlying diagnosis of infection (local or systemic) undergoing orthopaedic procedures have an elevated risk for subsequent VTE? https://icmphilly.com/?page_id=10685

97 – Is there a role for empirical treatment of patients with suspected, but not confirmed, VTE in the post-operative period? https://icmphilly.com/?page_id=10884

98 – Are certain patients identified to be at greater risk for venous thromboembolism than others? https://icmphilly.com/?page_id=10697

99 – If a patient is in an “increased risk” group for the development of VTE, are there certain agents which have increased efficacy over other anticoagulants? https://icmphilly.com/?page_id=10872

206 – Is Thromboelastography (TEG) useful in predicting the risk of VTE in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=10701

%d bloggers like this: